Aboud, O.; Liu, Y.; Dahabiyeh, L.; Abuaisheh, A.; Li, F.; Aboubechara, J.P.; Riess, J.; Bloch, O.; Hodeify, R.; Tagkopoulos, I.;
et al. Profile Characterization of Biogenic Amines in Glioblastoma Patients Undergoing Standard-of-Care Treatment. Biomedicines 2023, 11, 2261.
https://doi.org/10.3390/biomedicines11082261
AMA Style
Aboud O, Liu Y, Dahabiyeh L, Abuaisheh A, Li F, Aboubechara JP, Riess J, Bloch O, Hodeify R, Tagkopoulos I,
et al. Profile Characterization of Biogenic Amines in Glioblastoma Patients Undergoing Standard-of-Care Treatment. Biomedicines. 2023; 11(8):2261.
https://doi.org/10.3390/biomedicines11082261
Chicago/Turabian Style
Aboud, Orwa, Yin Liu, Lina Dahabiyeh, Ahmad Abuaisheh, Fangzhou Li, John Paul Aboubechara, Jonathan Riess, Orin Bloch, Rawad Hodeify, Ilias Tagkopoulos,
and et al. 2023. "Profile Characterization of Biogenic Amines in Glioblastoma Patients Undergoing Standard-of-Care Treatment" Biomedicines 11, no. 8: 2261.
https://doi.org/10.3390/biomedicines11082261
APA Style
Aboud, O., Liu, Y., Dahabiyeh, L., Abuaisheh, A., Li, F., Aboubechara, J. P., Riess, J., Bloch, O., Hodeify, R., Tagkopoulos, I., & Fiehn, O.
(2023). Profile Characterization of Biogenic Amines in Glioblastoma Patients Undergoing Standard-of-Care Treatment. Biomedicines, 11(8), 2261.
https://doi.org/10.3390/biomedicines11082261